The world’s accelerated search for a Covid-19 vaccine will be one of the key drivers of markets over the next three months.

Goldman Sachs’ researchers also agree that there is a “good chance” that at least one vaccine will be approved by the US Food and Drug Administration by the end of November and distributed by the middle of 2021.